Statistics

Total Visits

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial24

Select a period of time:

Number of views in the range

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial13

Views

Views
July 20243
August 20240
September 20246
October 20240
November 20242
December 20242
January 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
United Kingdom3
 

Top cities views

Views
Fort Worth1